Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?

Lynn K. Gordon; Alfredo A. Sadun; Greg Van Stavern; Andrew G. Lee

doi:10.1097/WNO.0000000000001377

Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?

Lynn K. Gordon, Alfredo A. Sadun, Greg Van Stavern, Andrew G. Lee

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	e535-e536
Journal	Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Volume	42
Issue number	2
DOIs	https://doi.org/10.1097/WNO.0000000000001377
State	Published - Jun 1 2022

ASJC Scopus subject areas

Ophthalmology
Clinical Neurology

Access to Document

10.1097/WNO.0000000000001377

Cite this

Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis? / Gordon, Lynn K.; Sadun, Alfredo A.; Van Stavern, Greg et al.

In: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, Vol. 42, No. 2, 01.06.2022, p. e535-e536.

Research output: Contribution to journal › Article › peer-review

@article{1aee158eef7d40a9882860b78fafcbaf,

title = "Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?",

author = "Gordon, {Lynn K.} and Sadun, {Alfredo A.} and {Van Stavern}, Greg and Lee, {Andrew G.}",

year = "2022",

month = jun,

day = "1",

doi = "10.1097/WNO.0000000000001377",

language = "English (US)",

volume = "42",

pages = "e535--e536",

journal = "Journal of Neuro-Ophthalmology",

issn = "1070-8022",